AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Psyence Biomedical Ltd.

$5.4 +$0.40 (+8.00%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$4.97
Day Range
$4.93$5.63
Year Range
$1.92$216.41
Market Cap
102.7K
AVG Volume
88.95K
Trailing/Forward PE
0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD)
-30M-20M-10M010M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Net Income (USD) by quarter
PeriodNet Income (USD)
25 Q2-753.25K
24 Q2141.47K
23 Q3-24.76M
23 Q2-877.22K
23 Q1-62.84K
22 Q4-24.49K
22 Q32.25M
22 Q2766.84K
22 Q12.04M
21 Q42.95M
Operating Income (USD)
-2M-1.5M-1M-500K021 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Operating Income (USD) by quarter
PeriodOperating Income (USD)
25 Q2-1.51M
24 Q2-1.16M
23 Q3-632.1K
23 Q2-176.16K
23 Q1-678.39K
22 Q4-1.04M
22 Q3-510.93K
22 Q2-244K
22 Q1-293.02K
21 Q4-326.9K
EBITDA (USD)
-2M02M4M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM EBITDA (USD) by quarter
PeriodEBITDA (USD)
25 Q2-749.17K
24 Q2146.2K
23 Q3-632.1K
23 Q2-877.22K
23 Q1-83.25K
22 Q4-33.12K
22 Q33.02M
22 Q21.05M
22 Q12.63M
21 Q43.69M
Cash Flows (USD)
-1M-750K-500K-250K021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
PBM Cash Flows (USD) by quarter
PeriodCash Flows (USD)
23 Q3-665
23 Q2-251.46K
23 Q1-251.43K
22 Q4-550.22K
22 Q3-86.26K
22 Q2-91.94K
22 Q1-125.03K
21 Q4-216.38K
21 Q3-819.68K
21 Q2-6.88K
EPS (USD)
-2024621 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM EPS (USD) by quarter
PeriodEPS (USD)
25 Q2-0.51
24 Q24.06
23 Q3-1.85
23 Q2-0.08
23 Q1-0.01
22 Q4-0
22 Q30.07
22 Q20.03
22 Q10.07
21 Q40.1
Expenses (USD)
0500K1M1.5M2MR&DSG&ACapex21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Expenses (USD) by quarter
PeriodExpenses (USD)
21 Q30
21 Q20
25 Q21.5M
24 Q21.16M
23 Q3632.11K
23 Q2184.71K
23 Q1512.09K
22 Q4771.49K
22 Q31.74M
22 Q2244K
22 Q1293.02K
21 Q4326.9K
Cash & Debt (USD)
02M4M6M8MCashShort Term Debt21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
25 Q27.2M
24 Q21.93M
23 Q3733
23 Q288.17K
23 Q19.8K
22 Q415.96K
22 Q3128.68K
22 Q2214.94K
22 Q1306.88K
21 Q4431.9K
Debt ratios
-10123421 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Debt ratios by quarter
PeriodDebt ratios
25 Q23.41
24 Q2-0.39
23 Q3-0.01
23 Q20.75
23 Q10.3
22 Q40.1
22 Q3-0.01
22 Q2-0.01
22 Q1-0.02
21 Q4-0.03
Return on Capital
-100000%0%100000%200000%300000%21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Return on Capital by quarter
PeriodReturn on Capital
25 Q2-6.35%
24 Q2-11.27%
23 Q3225694.88%
23 Q225.09%
23 Q1-4.3%
22 Q4-1.61%
22 Q30.92%
22 Q20.32%
22 Q10.85%
21 Q41.23%
Shares Outstanding
010M20M30M40M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Shares Outstanding by quarter
PeriodShares Outstanding
25 Q21.48M
24 Q2276.73K
23 Q313.39M
23 Q27.69M
23 Q18.04M
22 Q411.43M
22 Q332.67M
22 Q228.54M
22 Q128.54M
21 Q428.54M
Book Value Per Share (USD)
-5051021 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
25 Q28.01
24 Q2-4.54
23 Q3-0
23 Q2-0.45
23 Q10.18
22 Q40.13
22 Q37.49
22 Q28.5
22 Q18.47
21 Q48.4
Total Assets (USD)
0100M200M300M21 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q324 Q225 Q2
PBM Total Assets (USD) by quarter
PeriodTotal Assets (USD)
25 Q212.81M
24 Q22.25M
23 Q31.13K
23 Q212.68M
23 Q116.73M
22 Q416.4M
22 Q3258.93M
22 Q2256.48M
22 Q1255.87M
21 Q4255.98M
Employee Count
051015202420252026
PBM Employee Count by quarter
PeriodEmployee Count
202612
202512
202410
PE Ratio
0200004000060000med 20603.31Jan 24Feb 24Feb 24Feb 24Feb 24
PBM PE Ratio by quarter
PeriodPE Ratio
Feb 2413860.23
Feb 2417004.55
Feb 2420603.31
Feb 2436798.41
Jan 2459553.32
Free Cash Flow Yield
-0.08%-0.06%-0.04%-0.02%0%med -0%Feb 24Apr 24Jun 24Aug 24Sep 24Nov 24Jan 25
PBM Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Jan 25-0.07%
Jan 25-0.08%
Jan 25-0.06%
Dec 24-0.06%
Dec 24-0.04%
Dec 24-0.07%
Dec 24-0.06%
Nov 24-0.04%
Nov 24-0.04%
Nov 24-0.04%
Nov 24-0.02%
Nov 24-0.03%
Oct 24-0.02%
Oct 24-0.02%
Oct 24-0.02%
Oct 24-0.02%
Sep 24-0.02%
Sep 24-0.02%
Sep 24-0.01%
Sep 24-0.01%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Aug 24-0%
Jul 24-0%
Jul 24-0%
Jul 24-0.01%
Jul 24-0.01%
Jun 24-0.01%
Jun 24-0%
Jun 24-0%
Jun 24-0%
May 24-0%
May 24-0%
May 24-0%
May 24-0%
May 24-0%
Apr 24-0%
Apr 24-0%
Apr 24-0%
Apr 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Mar 24-0%
Feb 24-0.01%
Feb 24-0.01%
Feb 24-0%
Feb 24-0%
Jan 24-0%
EV/EBITDA
010000200003000040000med 13050.55Jan 24Feb 24Feb 24Feb 24Feb 24
PBM EV/EBITDA by quarter
PeriodEV/EBITDA
Feb 248779.59
Feb 2410771.15
Feb 2413050.55
Feb 2423308.26
Jan 2437720.84
Price to Book
00.511.5med 0.5Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
PBM Price to Book by quarter
PeriodPrice to Book
Sep 260.67
Sep 260.57
Aug 260.53
Aug 260.54
Aug 260.43
Aug 260.43
Jul 260.4
Jul 260.37
Jul 260.38
Jul 260.37
Jul 260.38
Jun 260.37
Jun 260.39
Jun 260.42
Jun 260.44
May 260.52
May 260.51
May 260.61
May 260.7
May 260.78
Apr 260.99
Apr 260.95
Apr 260.33
Apr 260.31
Mar 260.32
Mar 260.3
Mar 260.31
Mar 260.31
Feb 260.32
Feb 260.31
Feb 260.39
Feb 260.39
Jan 260.5
Jan 260.57
Jan 260.52
Jan 260.63
Jan 260.62
Dec 250.73
Dec 250.75
Dec 251.18
Dec 251.32
Nov 251.15
Nov 251.12
Psyence Biomedical Ltd.
PBM
Stockpicker

Video analysis: PBM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: PBM

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.